JP2021530488A5 - - Google Patents
Info
- Publication number
- JP2021530488A5 JP2021530488A5 JP2021500613A JP2021500613A JP2021530488A5 JP 2021530488 A5 JP2021530488 A5 JP 2021530488A5 JP 2021500613 A JP2021500613 A JP 2021500613A JP 2021500613 A JP2021500613 A JP 2021500613A JP 2021530488 A5 JP2021530488 A5 JP 2021530488A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- heterocyclyl
- pharmaceutical composition
- formula
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024052193A JP2024095711A (ja) | 2018-07-12 | 2024-03-27 | 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862696887P | 2018-07-12 | 2018-07-12 | |
| US62/696,887 | 2018-07-12 | ||
| PCT/EP2019/068448 WO2020011804A1 (en) | 2018-07-12 | 2019-07-09 | Alkoxy pyrazoles as soluble guanylate cyclase activators |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024052193A Division JP2024095711A (ja) | 2018-07-12 | 2024-03-27 | 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021530488A JP2021530488A (ja) | 2021-11-11 |
| JP2021530488A5 true JP2021530488A5 (enExample) | 2022-07-15 |
Family
ID=67314737
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500613A Pending JP2021530488A (ja) | 2018-07-12 | 2019-07-09 | 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール |
| JP2024052193A Pending JP2024095711A (ja) | 2018-07-12 | 2024-03-27 | 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024052193A Pending JP2024095711A (ja) | 2018-07-12 | 2024-03-27 | 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11690848B2 (enExample) |
| EP (1) | EP3820470B1 (enExample) |
| JP (2) | JP2021530488A (enExample) |
| KR (1) | KR20210032443A (enExample) |
| CN (1) | CN112384214A (enExample) |
| AU (1) | AU2019301887A1 (enExample) |
| BR (1) | BR112020025670A2 (enExample) |
| CA (1) | CA3103727A1 (enExample) |
| CL (1) | CL2021000023A1 (enExample) |
| EA (1) | EA202190193A1 (enExample) |
| MA (1) | MA53118A (enExample) |
| MX (1) | MX2021000405A (enExample) |
| PH (1) | PH12021550075A1 (enExample) |
| WO (1) | WO2020011804A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4496571A1 (en) * | 2022-03-21 | 2025-01-29 | Boehringer Ingelheim International GmbH | Soluble guanylate cyclase activators for treating portal hypertension |
| CN120225203A (zh) * | 2022-11-04 | 2025-06-27 | 勃林格殷格翰国际有限公司 | 用于治疗系统性硬化症的可溶性鸟苷酸环化酶活化剂 |
| WO2024123847A1 (en) | 2022-12-09 | 2024-06-13 | Boehringer Ingelheim International Gmbh | Solid forms of a sgc activator |
| CN121620369A (zh) * | 2023-08-16 | 2026-03-06 | 勃林格殷格翰国际有限公司 | 用于治疗临床显著门静脉高压和失代偿期肝硬化的可溶性鸟苷酸环化酶激活剂 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20191755T1 (hr) | 2012-09-07 | 2019-12-27 | Boehringer Ingelheim International Gmbh | Alkoksipirazoli kao aktivatori topljive gvanilat ciklaze |
| AU2017216429B2 (en) * | 2016-02-01 | 2022-10-06 | Cyclerion Therapeutics, Inc. | Use of sGC stimulators for the treatment of Nonalcoholic Steatohepatitis (NASH) |
| EP3458063A4 (en) * | 2016-05-18 | 2020-02-26 | Merck Sharp & Dohme Corp. | METHOD FOR USE OF TRIAZOLO-PYRAZINYL-SOLUBLE GUANYLATE CYCLASE ACTIVATORS IN FIBROTIC DISEASES |
-
2019
- 2019-07-09 WO PCT/EP2019/068448 patent/WO2020011804A1/en not_active Ceased
- 2019-07-09 JP JP2021500613A patent/JP2021530488A/ja active Pending
- 2019-07-09 BR BR112020025670-6A patent/BR112020025670A2/pt not_active IP Right Cessation
- 2019-07-09 AU AU2019301887A patent/AU2019301887A1/en not_active Abandoned
- 2019-07-09 KR KR1020217004281A patent/KR20210032443A/ko not_active Ceased
- 2019-07-09 US US17/258,759 patent/US11690848B2/en active Active
- 2019-07-09 EP EP19740509.5A patent/EP3820470B1/en active Active
- 2019-07-09 EA EA202190193A patent/EA202190193A1/ru unknown
- 2019-07-09 CN CN201980045881.XA patent/CN112384214A/zh active Pending
- 2019-07-09 CA CA3103727A patent/CA3103727A1/en active Pending
- 2019-07-09 MA MA053118A patent/MA53118A/fr unknown
- 2019-07-09 MX MX2021000405A patent/MX2021000405A/es unknown
-
2021
- 2021-01-06 CL CL2021000023A patent/CL2021000023A1/es unknown
- 2021-01-12 PH PH12021550075A patent/PH12021550075A1/en unknown
-
2024
- 2024-03-27 JP JP2024052193A patent/JP2024095711A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021530488A5 (enExample) | ||
| JP2023544476A5 (enExample) | ||
| JP2022532706A5 (enExample) | ||
| JP2009533427A5 (enExample) | ||
| CN113365998A (zh) | 用于parp抑制剂的吲哚并七元酰肟类似物 | |
| JP2019094345A5 (enExample) | ||
| JP2019034943A5 (enExample) | ||
| AU2017276170A1 (en) | Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of Hepatitis B | |
| JP2021535207A5 (enExample) | ||
| HRP20141048T1 (hr) | Spojevi, pripravci i metode | |
| RU2006134020A (ru) | Конденсированные производные пиразола | |
| JP2017518959A5 (enExample) | ||
| JP2020507589A5 (enExample) | ||
| JP2022522486A5 (enExample) | ||
| RU2001120726A (ru) | Комбинация ингибиторов fbpазы и сенсибилизаторов инсулина для лечения диабета | |
| JP2018529671A5 (enExample) | ||
| JP2003515523A5 (enExample) | ||
| JP2020518571A5 (enExample) | ||
| CN111655678A (zh) | 细胞凋亡信号调节激酶-1抑制剂及其应用 | |
| JP2024095711A (ja) | 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール | |
| JP2021533206A5 (enExample) | ||
| JP2024507414A5 (enExample) | ||
| JP2021528451A5 (enExample) | ||
| JP2024517769A5 (enExample) | ||
| JP2020520910A5 (enExample) |